Harte Hanks (HHS) Common Equity (2010 - 2026)

Harte Hanks (HHS) has 17 years of Common Equity data on file, last reported at $20.1 million in Q1 2026.

• On a quarterly basis, Common Equity fell 6.15% year-over-year to $20.1 million in Q1 2026; TTM through Mar 2026 was $20.1 million, a 6.15% decrease from a year earlier, with the FY2025 full-year figure at $20.5 million, down 5.36% from the prior year.
• Common Equity for Q1 2026 stood at $20.1 million, down from $20.5 million in the prior quarter.
• Over the last five years, Common Equity for HHS reached as high as $22.2 million in Q2 2025 and fell as low as -$20.6 million in Q1 2022.
• Historically, Common Equity has averaged $13.9 million across 5 years, with a median of $20.5 million in 2023.
• Across the five-year window, Common Equity soared 260.33% in 2023 and slipped 6.15% in 2026, its largest moves.
• Year by year, Common Equity stood at $18.8 million in 2022, then increased by 5.58% to $19.9 million in 2023, then gained by 9.23% to $21.7 million in 2024, then declined by 5.36% to $20.5 million in 2025, then retreated by 2.06% to $20.1 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $20.1 million in Q1 2026, $20.5 million in Q4 2025, and $19.9 million in Q3 2025.